These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 35552087)

  • 1. Circ_0000514 promotes the malignant biological behaviors of non-small cell lung cancer cells by modulating miR-330-5p and HMGA2.
    Jia L; Liu M; An L; Wang H; Wang X
    Pathol Res Pract; 2022 Jul; 235():153913. PubMed ID: 35552087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circular RNA circ_0003028 contributes to tumorigenesis by regulating GOT2 via miR-1298-5p in non-small cell lung cancer.
    Guan H; Sun C; Gu Y; Li J; Ji J; Zhu Y
    Bioengineered; 2021 Dec; 12(1):2326-2340. PubMed ID: 34077306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circ_0006988 promotes the proliferation, metastasis and angiogenesis of non-small cell lung cancer cells by modulating miR-491-5p/MAP3K3 axis.
    Yang C; Shi J; Wang J; Hao D; An J; Jiang J
    Cell Cycle; 2021 Jul; 20(13):1334-1346. PubMed ID: 34189997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Circ_0001666 promotes the proliferation and inhibits apoptosis of non-small cell lung cancer cells by targeting the miR-330-5p/HMGA2 axis].
    Xiang BL; Su J; Liu Y
    Sheng Li Xue Bao; 2021 Jun; 73(3):491-500. PubMed ID: 34230950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circ_0072088 promotes the development of non-small cell lung cancer via the miR-377-5p/NOVA2 axis.
    Tan Z; Cao F; Jia B; Xia L
    Thorac Cancer; 2020 Aug; 11(8):2224-2236. PubMed ID: 32524752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hsa_circ_0069244 acts as the sponge of miR-346 to inhibit non-small cell lung cancer progression by regulating XPC expression.
    Shi J; Wang H; Feng W; Huang S; An J; Wang L; Jiang J
    Hum Cell; 2021 Sep; 34(5):1490-1503. PubMed ID: 34228324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circ_0001955 promotes the progression of non-small cell lung cancer via miR-769-5p/EGFR axis.
    Ding L; Feng Y; Li L
    Cell Cycle; 2022 Nov; 21(22):2433-2443. PubMed ID: 35920610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CircRNA OXCT1 promotes the malignant progression and glutamine metabolism of non-small cell lung cancer by absorbing miR-516b-5p and upregulating SLC1A5.
    Luo H; Peng J; Yuan Y
    Cell Cycle; 2023 May; 22(10):1182-1195. PubMed ID: 35482822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circ_0000267 promotes gastric cancer progression via sponging MiR-503-5p and regulating HMGA2 expression.
    Cai X; Nie J; Chen L; Yu F
    Mol Genet Genomic Med; 2020 Feb; 8(2):e1093. PubMed ID: 31845519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circ_0074027 Contributes to Non-Small Cell Lung Cancer Progression by Upregulating
    Yu C; Ying J; Yu K; Shen W; Jiang M
    Cancer Biother Radiopharm; 2022 Mar; 37(2):73-83. PubMed ID: 32580576
    [No Abstract]   [Full Text] [Related]  

  • 11. CircRNA Circ-CCND1 Aggravates Hepatocellular Carcinoma Tumorigenesis by Regulating the miR-497-5p/HMGA2 Axis.
    Zheng S; Hou J; Chang Y; Zhao D; Yang H; Yang J
    Mol Biotechnol; 2022 Feb; 64(2):178-186. PubMed ID: 34564768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CircRNA hsa_circ_0075048 promotes the malignant progression of non-small cell lung cancer by up-regulating HMGB2 expression via targeting miR-1225-5p.
    Zhang J; Mao J
    Histol Histopathol; 2023 Jun; 38(6):709-724. PubMed ID: 36416408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circ_0074027 contributes to non-small cell lung cancer progression through positively modulating RHOA via sequestering miR-2467-3p.
    Duan Z; Wei S; Liu Y
    J Bioenerg Biomembr; 2021 Apr; 53(2):223-233. PubMed ID: 33687619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soy isoflavone genistein inhibits hsa_circ_0031250/miR-873-5p/FOXM1 axis to suppress non-small-cell lung cancer progression.
    Yu Y; Xing Y; Zhang Q; Zhang Q; Huang S; Li X; Gao C
    IUBMB Life; 2021 Jan; 73(1):92-107. PubMed ID: 33159503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circ_0003998 Regulates the Progression and Docetaxel Sensitivity of DTX-Resistant Non-Small Cell Lung Cancer Cells by the miR-136-5p/CORO1C Axis.
    Zhang W; Song C; Ren X
    Technol Cancer Res Treat; 2021; 20():1533033821990040. PubMed ID: 33511909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circular RNA circ_0001287 inhibits the proliferation, metastasis, and radiosensitivity of non-small cell lung cancer cells by sponging microRNA miR-21 and up-regulating phosphatase and tensin homolog expression.
    Zhang CC; Li Y; Feng XZ; Li DB
    Bioengineered; 2021 Dec; 12(1):414-425. PubMed ID: 33467964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circular RNA hsa_circ_0002360 promotes non-small cell lung cancer progression through upregulating matrix metalloproteinase 16 and sponging multiple micorRNAs.
    Zhang Y; Zeng S; Wang T
    Bioengineered; 2021 Dec; 12(2):12767-12777. PubMed ID: 34747300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The circ-PITX1 promotes non-small cell lung cancer development via the miR-30e-5p/ITGA6 axis.
    Li W; Yang P; Zhong C; Shen X; Shi X; Li X
    Cell Cycle; 2022 Feb; 21(3):304-321. PubMed ID: 35007184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. circ_0007385 served as competing endogenous RNA for miR-519d-3p to suppress malignant behaviors and cisplatin resistance of non-small cell lung cancer cells.
    Ye Y; Zhao L; Li Q; Xi C; Li Y; Li Z
    Thorac Cancer; 2020 Aug; 11(8):2196-2208. PubMed ID: 32602212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circular RNA circ_0000376 promotes paclitaxel resistance and tumorigenesis of non-small cell lung cancer via positively modulating KPNA4 by sponging miR-1298-5p.
    Hu S; Zhang Q; Sun J; Xue J; Wang C
    Thorac Cancer; 2023 Aug; 14(22):2116-2126. PubMed ID: 37455373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.